Skip to main content
Premium Trial:

Request an Annual Quote

Decode, Thinner by 200 Staff, Pens Obesity R&D Collab With Merck

NEW YORK, Sept. 27 - Decode Genetics and Merck will partner to study the genetic components of obesity, the companies said today.

 

For the next three years, the two firms will use Decode's Clinical Gene Miner technology to hopefully gain a "detailed understanding" of targets provided through Merck's in-house gene-expression research.

Decode stands to pocket "substantial" research funding, tech-access and license fees, milestone payments, and potential royalties. Though none of the financial details was disclosed, Decode, which today announced it axed 200 employees, said it stands to earn $90 million if Merck is able to develop and sell "more than one" product from the collaboration.

 

Decode has already done some work in obesity. The Icelandic company said it has mapped "several key genes" linked to obesity, and has put together "detailed" genotypic and clinical data from more than 10,000 adult volunteers from its home country.

 

Click here for more information.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.